Login to Your Account



Imbruvica RESONATEs with docs ready for new first-line CLL treatment

By Michael Fitzhugh
Staff Writer

Monday, December 7, 2015

ORLANDO, Fla. – Treating previously untreated older patients with chronic lymphocytic leukemia with Imbruvica proved superior to standard of care treatment with the chemotherapy chlorambucil.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription